Cocrystal Pharma

COCPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$22.923 M

$1.19 +0.00%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$8.83M

Loss-making

Shares outstanding

19,263,200

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#390Korsana BiosciencesKRSA$23.4M
#391Psyence BiomedicalPBM$23.3M
#392Cocrystal PharmaCOCP$22.9M
#393Atossa TherapeuticsATOS$22.6M
#394Cellectar BiosciencesCLRB$21.1M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of Cocrystal Pharma, worth $80.4K. Grants and option exercises are excluded.

Phillip Md Et Al Frost$9.82K
10,000 shares at $0.98 on 5 Aug 2026 · filed 6 Aug 2026
Phillip Md Et Al Frost$70.6K
75,000 shares at $0.94 on 3 Aug 2026 · filed 5 Aug 2026

What if Cocrystal Pharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,569,520

Per share 1,318,924× higher

Bitcoin $1.74T

$90,413.59

Per share 75,978× higher

Nvidia $5.52T

$286,337.01

Per share 240,619× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Cocrystal Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.